NCT05521230 is a Phase 1 clinical trial of Cymenol mouthwash in Healthy, sponsored by University of Santiago de Compostela.

Who is sponsoring NCT05521230?

NCT05521230 is sponsored by University of Santiago de Compostela.

What drugs are being tested in NCT05521230?

Interventions in NCT05521230: Placebo Mouthwash, Cymenol mouthwash.

What condition does NCT05521230 study?

NCT05521230 studies Healthy, Dental Plaque.

Is NCT05521230 still recruiting?

NCT05521230 is currently completed. Last updated 30 August 2022.

Last reviewed 2022-08-30 · How we verify

NCT05521230

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Short-Term Anti-plaque Effect of Cymenol Mouthwash Analysed Using Dentius Deep Plaque Software

Completed Phase 1 Last updated 30 August 2022

What this trial tests

Phase 1 trial testing Placebo Mouthwash in Healthy in 60 participants. Completed in 30 April 2022.

Timeline

1 September 2021

Primary endpoint
31 March 2022

30 April 2022

Quick facts

Lead sponsor	University of Santiago de Compostela
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	60
Start date	1 September 2021
Primary completion	31 March 2022
Estimated completion	30 April 2022
Sites	1 location across Spain

Drugs / interventions tested

Placebo Mouthwash — full drug profile →
Cymenol mouthwash — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →
Dental Plaque — all drugs for Dental Plaque →

Sponsor

University of Santiago de Compostela

Who can join

Adults 20 to 45, any sex, with Healthy or Dental Plaque. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this project was to investigate the short-term in situ anti-plaque effect of cymenol, using the Dentius Deep Plaque software

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Short-term anti-plaque effect of a cymenol mouthwash analysed using the DenTiUS Deep Plaque software: a randomised clinical trial.
Suárez-Rodríguez B, Regueira-Iglesias A, Blanco-Pintos T, Balsa-Castro C, et al · · 2023 · cited 2× · PMID 37573292 · DOI 10.1186/s12903-023-03256-9

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other University of Santiago de Compostela trials

Trials by the same sponsor.

NCT07466004 — PERMA-Based Mobile Psychological Intervention With and Without Telephone Support for University Students · NA · not yet recruiting
NCT07343284 — Nursing Health Education to Improve Functionality and Quality of Life After Ischemic Stroke · NA · not yet recruiting
NCT07430748 — REGENFAST vs L-PRF in Periodontal Regeneration · EARLY_PHASE1 · active not recruiting
NCT07355673 — The Influence of Isolation Techniques in Gingival Irritation During an In-office Bleaching · NA · completed
NCT07355647 — Efficacy of a Desensitizing Agent During In-Office Bleaching · EARLY_PHASE1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05521230 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Santiago de Compostela
Last refreshed: 30 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05521230.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing